首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Converging micro-nano-bio technologies towards integrated biomedical systems: State of the art and future perspectives under the EU-Information Communication Technologies Program
【24h】

Converging micro-nano-bio technologies towards integrated biomedical systems: State of the art and future perspectives under the EU-Information Communication Technologies Program

机译:融合微纳米生物技术朝向综合生物医学系统:欧盟信息和通信技术计划下的艺术状态和未来的观点

获取原文

摘要

Research and development at the convergence of microelectronics, nano-materials, biochemistry, measurement technology and information technology is leading to a new class of biomedical systems and applications e.g. molecular imaging, point of care testing, gene therapy and bionics (including on and inside the body sensors and other miniaturised smart systems) which are expected to revolutionise the healthcare provision and quality of life. In particular they are expected to identify diseases at the earliest possible stage, intervene before symptomatic disease becomes apparent and monitor both the progress of the diseases and the effect of intervention and therapeutic procedures. The group of EC-funded projects on Micro-Nano-Bio Convergence Systems, "so-called" MNBS, is made by projects developing systems that use a vast array of technologies to integrate across traditional boundaries between the micro-nano-bio, and info worlds, enabling a wide range of applications from health care to food quality monitoring. It includes mainly two sub-groups, one dealing with systems for in vitro molecular diagnosis and biological/biochemical analysis and the other is dealing with systems for in vivo interaction with the human body. Current status of development and future challenges, technological and socioeconomic, are briefly presented in this paper as background introductory information to the mini-symposium on MNBS. Relevant examples of R&D within the group will be presented in the mini-symposium.
机译:微电子,纳米材料,生物化学,测量技术和信息技术融合的研究与开发导致新一类生物医学系统和应用。分子成像,护理点测试,基因治疗和仿生菌(包括身体传感器和其他小型化的智能系统),预计将彻底改变医疗保健提供和生活质量。特别是,预计它们将在最早的可能阶段识别疾病,在症状性疾病之前进行干预,并监测疾病的进展以及干预和治疗程序的效果。关于微纳米生物收敛系统的EC资助项目,“所谓的”MNB,是由项目开发系统制造的,该系统使用了广泛的技术来跨越微纳米生物之间的传统边界,以及信息世界,从医疗保健方面实现各种应用,以食品质量监测。它主要包括两个子组,一个涉及体外分子诊断和生物学/生物化学分析的系统,另一个是与人体相互作用的系统处理。的发展和未来的挑战,技术和社会经济现状,简要本文作为背景介绍资料上MNBS小型研讨会上宣读。本集团内的R&D的相关实例将在迷你研讨会中提出。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号